Prescription Antiemetic Medicine | Chemotherapy-Induced Nausea & Vomiting Prevention | 3-Capsule Combination Pack
Chemotherapy is an important part of cancer treatment, but nausea and vomiting can make the experience especially challenging. Managing these symptoms is an essential part of supportive cancer care.
Apreon Aprepitant Combo-Pack, manufactured by Ferozsons Laboratories Limited, Pakistan, is a prescription antiemetic medicine designed for use as part of a combination treatment to help prevent nausea and vomiting associated with certain chemotherapy regimens.
The pack contains three oral capsules in two strengths: one 125mg capsule and two 80mg capsules.
Aprepitant belongs to a class of medicines known as neurokinin-1 (NK1) receptor antagonists. It acts on signaling pathways involved in triggering nausea and vomiting.
Apreon is intended for use under medical supervision, generally alongside other prescribed antiemetic medicines. It is not a general-purpose remedy for nausea or vomiting.
Aprepitant: An NK1 receptor antagonist used to help prevent chemotherapy-induced nausea and vomiting.
Dual-Strength Combo-Pack: Contains one 125mg capsule and two 80mg capsules.
Acute and Delayed Symptom Prevention: Aprepitant is used in regimens addressing nausea and vomiting occurring soon after chemotherapy and during subsequent days.
Combination Antiemetic Treatment: Commonly used with other antiemetic medicines selected by an oncology specialist.
Three-Capsule Pack: Designed for a prescribed treatment regimen.
Oral Administration: Capsules intended to be taken by mouth.
Prescription Only: Requires professional medical assessment and supervision.
Apreon contains aprepitant, a prescription medicine used in the prevention of certain types of chemotherapy-induced nausea and vomiting (CINV).
It may be included in antiemetic treatment regimens for:
Highly Emetogenic Chemotherapy (HEC)
Some chemotherapy regimens carry a particularly high risk of nausea and vomiting. Aprepitant may be prescribed with other medicines to help reduce this risk.
Moderately Emetogenic Chemotherapy (MEC)
Aprepitant may also be used with other antiemetics for selected moderately emetogenic chemotherapy regimens.
Delayed Chemotherapy-Induced Nausea and Vomiting
Symptoms may occur beyond the first 24 hours after chemotherapy. Aprepitant helps address pathways involved in delayed nausea and vomiting.
Important: Apreon is used primarily for prevention. It should not be relied upon as an immediate rescue medicine for uncontrolled or established vomiting.
The exact indications approved for Apreon in Pakistan should be confirmed against its current prescribing information.
Aprepitant blocks neurokinin-1 (NK1) receptors, which normally respond to a signaling substance called substance P.
Substance P is involved in activating pathways associated with nausea and vomiting.
By blocking NK1 receptors, aprepitant helps reduce these signals and contributes to preventing chemotherapy-induced vomiting.
It is usually used alongside other antiemetic medicines because different treatments target different nausea and vomiting pathways.
| Capsule Strength | Quantity |
|---|---|
| Aprepitant 125mg | 1 Capsule |
| Aprepitant 80mg | 2 Capsules |
| Total | 3 Capsules |
The combination is intended for a specific clinician-prescribed antiemetic regimen.
| Specification | Details |
|---|---|
| Product Name | Apreon Combo-Pack |
| Generic Name | Aprepitant |
| Active Ingredient | Aprepitant |
| Strengths | 80mg and 125mg |
| Pack Size | 3 Capsules |
| 80mg Capsules | 2 |
| 125mg Capsules | 1 |
| Dosage Form | Capsules U.S.P. |
| Therapeutic Class | NK1 Receptor Antagonist |
| Medicine Category | Antiemetic |
| Route of Administration | Oral |
| Manufacturer | Ferozsons Laboratories Limited |
| Additional Branding | B&F Biosciences |
| Country | Pakistan |
| DRAP Registration No. | 068204 |
| Prescription Status | Rx Only |
Apreon must be taken according to your oncology specialist's prescription.
For reference, a commonly used three-day aprepitant regimen involves a 125mg capsule on the first day and an 80mg capsule on each of the next two days.
This is general information about established aprepitant regimens, not a personalized prescription. The exact timing, suitability, and accompanying antiemetic medicines must be determined by the treating clinician.
General instructions:
Follow the exact treatment plan supplied by your oncology team.
Check the capsule strength before each prescribed administration.
Swallow the capsules whole with water.
Do not independently change the order, timing, or number of capsules.
Do not repeat the course without medical instructions.
Contact your oncology team if vomiting prevents you from keeping your prescribed medicines down.
Before taking Apreon, inform your healthcare professional about:
Any allergy to aprepitant or other ingredients in the capsules.
Liver disease or other significant medical conditions.
Pregnancy or breastfeeding.
All prescription medicines, non-prescription medicines, and herbal supplements.
Any medicine containing pimozide.
Use of warfarin or other anticoagulants.
Use of hormonal contraceptives.
Other cancer-treatment medicines.
Drug interactions are especially important.
Aprepitant affects drug-metabolizing pathways, including CYP3A4, and may alter the effects of certain medicines.
It must not be combined with pimozide. Patients taking warfarin may need additional INR monitoring. Aprepitant can also reduce the effectiveness of hormonal contraceptives during treatment and for 28 days after the last dose, so appropriate backup or alternative contraception is important.
Your healthcare professional must review the complete treatment regimen for potential interactions.
Aprepitant may cause adverse effects such as:
Tiredness or fatigue
Hiccups
Constipation
Diarrhoea
Headache
Reduced appetite
Other digestive symptoms
Rare but serious reactions may include allergic or hypersensitivity reactions.
If severe symptoms or an allergic reaction occur, seek prompt medical attention.
Patients receiving chemotherapy should contact their oncology team for persistent vomiting, dehydration, inability to take fluids, or other concerning symptoms.
According to the photographed packaging:
Do not store above 30°C.
Protect from excessive heat, moisture, and sunlight.
Keep medicines out of reach of children.
Store in the original packaging as appropriate.
Do not use after the printed expiry date.
What is Apreon Combo-Pack?
Apreon is a prescription combination pack containing aprepitant capsules in two strengths: one 125mg capsule and two 80mg capsules.
What is Apreon used for?
Apreon is used as part of prescribed antiemetic treatment to help prevent nausea and vomiting caused by certain chemotherapy regimens.
What is the generic name of Apreon?
The generic name is aprepitant.
How many capsules are in one Apreon Combo-Pack?
The package contains three capsules: one 125mg capsule and two 80mg capsules.
How does Apreon work?
Aprepitant blocks NK1 receptors, reducing the action of substance P in pathways involved in nausea and vomiting.
Is Apreon used during chemotherapy?
Yes. Aprepitant is commonly prescribed as part of a combination antiemetic regimen associated with selected chemotherapy treatments.
Can Apreon stop vomiting immediately?
Apreon is primarily used to prevent chemotherapy-induced nausea and vomiting. It is not intended to replace rescue treatment for uncontrolled symptoms.
Is Apreon an antibiotic?
No. Apreon is an antiemetic medicine, not an antibiotic.
Is Apreon a steroid?
No. Aprepitant is an NK1 receptor antagonist, not a corticosteroid. It may, however, be prescribed alongside corticosteroids in certain antiemetic regimens.
Can Apreon be used without a prescription?
No. The packaging is marked Rx Only, and its use must follow professional medical instructions.
Can Apreon interact with other medicines?
Yes. Aprepitant can interact with several medicines, including pimozide, warfarin, hormonal contraceptives, and certain cancer-treatment medicines.
Can pregnant patients take Apreon?
A qualified healthcare professional must assess the potential benefits and risks before use during pregnancy.
Can children use Apreon Combo-Pack?
Suitability depends on age, clinical circumstances, the prescribed regimen, and locally approved product information. Do not assume the adult combo-pack is appropriate for children.
Who manufactures Apreon?
Apreon is manufactured by Ferozsons Laboratories Limited, Pakistan.
What is the price of Apreon Combo-Pack in Pakistan?
The DRAP PharmaPrice Index lists a maximum retail price of Rs. 6,238.09 for the three-capsule combo-pack, effective July 22, 2026. Retail prices and availability should be verified.
Prescription Medicine (Rx Only) – Oral Use
Apreon contains aprepitant and must be used according to a qualified healthcare professional's prescription.
This information is provided for product identification and general medical education. It does not replace the locally approved product leaflet, an individual prescription, or professional oncology advice.
Sale, dispensing, and advertising must comply with applicable pharmaceutical regulations.